CAPR R&D Expenses
Capricor Therapeutics Inc · R&D Expenses
CAPR R&D Expenses
Latest reported$28.87Mperiod ending
CAPR Quarterly R&D Expenses ($0.00 → $28.87M)
Quarterly R&D Expenses
High-resolution chart · PNG
CAPR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 28,866,292 | |
| 27,376,912 | |
| 23,132,671 | |
| 20,359,098 | |
| 22,047,254 | |
| 18,915,572 | |
| 14,554,936 | |
| 11,807,867 | |
| 12,504,769 | |
| 11,101,013 | |
| 9,940,167 | |
| 10,028,964 | |
| 8,817,389 | |
| 7,661,519 | |
| 6,231,806 | |
| 5,504,356 | |
| 4,965,088 | |
| 5,115,699 | |
| 4,263,533 | |
| 2,513,915 | |
| 3,497,275 | |
| 3,296,322 | |
| 2,745,104 | |
| 2,629,267 | |
| 1,927,473 | |
| 1,155,156 | |
| 828,749 | |
| 857,764 | |
| 1,644,000 | |
| 1,811,000 | |
| 2,849,000 | |
| 3,132,000 | |
| 3,389,000 | |
| 2,697,000 | |
| 2,518,000 | |
| 1,862,000 | |
| 3,128,000 | |
| 3,257,000 | |
| 2,666,000 | |
| 4,727,000 | |
| 4,308,000 | |
| 4,341,000 | |
| 3,331,000 | |
| 3,193,000 | |
| 3,427,000 | |
| 3,807,000 | |
| 2,584,000 | |
| 1,967,000 | |
| 1,856,000 | |
| 1,375,000 | |
| 5,067,000 | |
| 1,011,000 | |
| 1,312,000 | |
| 1,191,000 | |
| 46,984 | |
| 179,142 | |
| 332,450 | |
| 465,353 | |
| 1,342,000 | |
| 1,470,000 | |
| 702,930 | |
| 622,332 | |
| 563,062 | |
| 1,149,000 | |
| 1,056,000 | |
| 1,313,000 | |
| 889,272 | |
| 1,149,000 | |
| 1,103,000 | |
| 1,325,000 | |
| 2,054,000 | |
| 2,557,000 | |
| 2,889,000 | |
| 1,978,000 | |
| 1,527,000 | |
| 2,176,000 | |
| 863,029 | |
| 558,248 | |
| 0 | |
| 774,772 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |